Alan Rein

Title: Alan Rein: Innovator in Anti-Viral Research

Introduction

Alan Rein is a notable inventor based in Columbia, MD (US), recognized for his contributions to the field of virology. He holds a total of 3 patents that focus on innovative methods for inhibiting viral replication, particularly in the context of retroviruses.

Latest Patents

Rein's latest patents include significant advancements in the identification of anti-HIV compounds that inhibit virus assembly and the binding of nucleocapsid protein to nucleic acid. One of his inventions provides methods and pharmaceutical compositions aimed at disrupting viral nucleocapsid binding to nucleic acids through the administration of stibonic acid or diphenyl compounds. Another patent focuses on oligonucleotides that specifically bind to retroviral nucleocapsid proteins with high affinity, serving as molecular decoys that inhibit viral replication. These inventions also include targeted molecules comprising high-affinity oligonucleotides, assays for selecting test compounds, and related kits.

Career Highlights

Throughout his career, Alan Rein has worked with prestigious organizations, including the National Institutes of Health, a component of the US Department of Health & Human Services, and The United States of America. His work has significantly impacted the understanding and treatment of viral infections.

Collaborations

Rein has collaborated with notable colleagues such as Louis E. Henderson and Robert J. Fisher, contributing to a rich environment of innovation and research in the field of virology.

Conclusion

Alan Rein's work exemplifies the critical role of inventors in advancing medical science, particularly in the fight against viral diseases. His patents reflect a commitment to developing effective treatments that can potentially save lives.